Ou Bai, Md/phd
Clinical trials sponsored by Ou Bai, Md/phd, explained in plain language.
-
New hope for lymphoma patients with hepatitis b: maintenance drug aims to prevent relapse
Disease control Recruiting nowThis study tests whether the drug chidamide can help keep diffuse large B-cell lymphoma (DLBCL) from coming back in patients who also have hepatitis B. Participants must have achieved complete remission after initial chemotherapy (R-CHOP). The trial will compare progression-free …
Phase: PHASE3 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New hope for elderly lymphoma patients: targeted combo shows promise
Disease control Recruiting nowThis study tests a new drug combination for people aged 70 and older who have a specific type of aggressive lymphoma (DLBCL) that has not been treated before. Participants receive a targeted drug (chidamide) plus a reduced-dose chemotherapy, followed by maintenance therapy with c…
Phase: PHASE2 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated May 22, 2026 13:51 UTC